↓ Skip to main content

Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's Disease

Overview of attention for article published in Frontiers in Neurology, January 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
8 X users

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's Disease
Published in
Frontiers in Neurology, January 2022
DOI 10.3389/fneur.2021.716126
Pubmed ID
Authors

Eduard Linetsky, Suaad Abd Elhadi, Max Bauer, Akiva Gallant, Montaser Namnah, Sagit Weiss, Daniel Segal, Ronit Sharon, David Arkadir

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 23%
Librarian 1 8%
Student > Doctoral Student 1 8%
Other 1 8%
Student > Bachelor 1 8%
Other 1 8%
Unknown 5 38%
Readers by discipline Count As %
Medicine and Dentistry 5 38%
Pharmacology, Toxicology and Pharmaceutical Science 2 15%
Biochemistry, Genetics and Molecular Biology 1 8%
Unknown 5 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2022.
All research outputs
#8,420,283
of 25,765,370 outputs
Outputs from Frontiers in Neurology
#5,155
of 14,776 outputs
Outputs of similar age
#178,839
of 519,415 outputs
Outputs of similar age from Frontiers in Neurology
#160
of 704 outputs
Altmetric has tracked 25,765,370 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 14,776 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 519,415 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 704 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.